yoni athéa

* Build and manage the regional medical action plan (implementation and follow-up) * Participation to the national medical strategy elaboration (KOL mapping) * Lead, implement and follow medical projects with KOLs (partnerships, donations, IITs, clinical trials, medical/scientific queries, ...) * KOL management : organize/lead medical meetings with KOLs (ex: boards, symposium, scientific meetings, congresses, stand alone events, oral communications, posters, …) * Anticipate product launches and communicate the scientific and medical profile of drugs and their environment * Publications research and scientific monitoring * Create, adapt and deliver training on medical knowledge to hospital Reps * Support marketing to create promotional materials aligned with medical knowledge * Ensure transversal management with Reps and collaboration with Sales and Marketing team

* Scouting/screening opportunities for licensing agreements, co-promotion and acquisitions * Cross-functional team working to identify BD opportunities and/or to lead due diligences * Evaluating opportunities with scientific data, market potential, competitive assessment, regulatory interactions, intellectual property and financial and valuation analyses * Summarizing due diligence and communicating recommendations to senior management * Assisting in negotiating deal terms with target companies/products

* Project contribution and analysis in almost 35 consultancy projects for life sciences companies, for public institutions and private investors * Strategic/commercial Due Diligences, evaluation of entrepreuneurial projects and build-up strategies for corporates investments or large investments funds * Business development studies: target screening of companies to acquire, licensing-out, buyout of innovative products, set-up of partnerships for investment funds or major pharmaceutical indutries * Business plans, technical & economical feasibility studies, strategic positioning and market entry strategy studies for different kind of life sciences companies : large, mid and small pharmaceutical industries, biotech companies, large and small diagnostic industries and medical devices companies * Positioning of Life Science Cluster and sector analysis (LEEM * Biomarker study 2009-2010)